Thyrocare Technologies profit and loss

Latest FY26

Revenue: ₹829cr+20.6% on FY25
EBITDA: ₹262cr+37.7% on FY25
Net profit: ₹163cr+79.4% on FY25
EPS: ₹10.27−40.0% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	930	829	687	572	527	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	17.1	17.0	14.8	9.4	8.4
	947	846	702	581	535
	235	219	188	165	157
	1.2	1.1	2.0	2.5	6.1
	0.1	−0.2	0.8	−0.3	0.2
	157	138	127	108	106
	4.4	2.8	3.1	4.2	2.4
	61.7	58.6	55.3	47.0	38.7
	238	209	179	160	137
	697	628	555	486	448
	299	262	190	137	120
	238	203	135	90.4	81.3
Profit
	251	218	147	95.6	87.4
	−51.1	−6.2	0.0	0.0	0.0
	199	211	147	95.6	87.4
	64.7	57.3	47.8	30.1	30.2
	−6.3	−7.3	6.9	−3.6	−5.9
	58.5	50.0	54.7	26.5	24.2
	2.4	1.4	−1.4	0.4	1.2
	143	163	90.8	69.5	64.4
	141	161	92.2	69.1	63.2
	0.3	0.4	−0.8	0.3	1.5
	144	163	90.0	69.8	65.9
	144	163	91.5	70.8	64.5
	−0.9	−0.2	−0.8	−1.3	−0.1
Per share
	₹9.00	₹10.27	₹17.13	₹13.42	₹12.16
	₹8.96	₹10.24	₹17.08	₹13.40	₹12.14
Other comprehensive income — detail
	0.3	0.4	−0.8	—	—
	0.2	0.5	—	—	2.0
	−0.1	0.1	1.0	—	—
	—	—	—	−0.4	0.5
	—	—	−0.3	—	—
	—	—	—	0.1	—
	144	163	90.7	71.1	66.0
	−0.9	−0.2	−0.8	−1.3	−0.1
Per share — as-filed variants
	₹9.00	₹10.27	₹17.13	₹13.42	₹12.16
	₹8.96	₹10.24	₹17.08	₹13.40	₹12.14
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	694	609	496	405	363
	74.6%	73.5%	72.2%	70.9%	69.0%
Adjusted (ex-exceptional items) — derived
	251	218	147	95.6	87.4
	−51.1	−6.2	0.0	0.0	0.0
	179	168	90.8	69.5	64.4
	₹11.27	₹10.57	₹17.13	₹13.42	₹12.16

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

THYROCARE₹515.50

Thyrocare Technologies Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersLALPATHLAB METROPOLIS VIJAYA SUPRIYA VIYASH STAR SPARC YATHARTHMcap ₹8,205 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	526.7	571.9	687.4	829.0	930.3
Other Income	8.4	9.4	14.8	17.0	17.1
Total Income	535.1	581.3	702.2	846.0	947.4
Expenses
+ Cost of Materials Consumed	156.9	164.5	188.3	218.7	234.6
+ Purchases of Stock-in-Trade	6.1	2.5	2.0	1.1	1.2
+ Changes in Inventories	0.2	-0.3	0.8	-0.2	0.1
+ Employee Benefit Expense	106.2	107.9	126.8	138.1	156.7
+ Finance Costs	2.4	4.2	3.1	2.8	4.4
+ Depreciation & Amortisation	38.7	47.0	55.3	58.6	61.7
+ Other Expenses	137.2	159.9	179.1	209.4	238.3
Total Expenses	447.7	485.7	555.3	628.4	696.9
EBITDA	120.1	137.4	190.4	262.0	299.5
EBIT	81.3	90.4	135.1	203.5	237.8
Profit
PBT before Exceptional Items	87.4	95.6	146.9	217.7	250.5
+ Exceptional Items	0.0	0.0	0.0	-6.2	-51.1
Pretax Income	87.4	95.6	146.9	211.5	199.4
+ Current Tax	30.2	30.1	47.8	57.3	64.7
+ Deferred Tax	-5.9	-3.6	6.9	-7.3	-6.3
Tax Expense	24.2	26.5	54.7	50.0	58.5
+ Share of Associates & JVs	1.2	0.4	-1.4	1.4	2.4
Net Income	64.4	69.5	90.8	162.9	143.3
+ Net Income — Continuing Ops	63.2	69.1	92.2	161.5	140.9
+ Other Comprehensive Income	1.5	0.3	-0.8	0.4	0.3
Total Comprehensive Income	65.9	69.8	90.0	163.2	143.6
Net Income to Common	64.5	70.8	91.5	163.1	144.2
Minority Interest	-0.1	-1.3	-0.8	-0.2	-0.9
Per Share
Basic EPS	12.16	13.42	17.13	10.27	9.00
Diluted EPS	12.14	13.40	17.08	10.24	8.96
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.8	0.4	0.3
+ Items NOT to be Reclassified to P&L	2.0	—	—	0.5	0.2
+ Tax on Items NOT to be Reclassified	—	—	1.0	0.1	-0.1
+ Tax on Items NOT to be Reclassified — alt tag	0.5	-0.4	—	—	—
+ Tax on Items to be Reclassified	—	—	-0.3	—	—
+ Tax on Items to be Reclassified — alt tag	—	0.1	—	—	—
Comprehensive Income — Owners of Parent	66.0	71.1	90.7	163.4	144.5
Comprehensive Income — Non-controlling Interests	-0.1	-1.3	-0.8	-0.2	-0.9
Per Share — as-filed variants
Basic EPS — Continuing Operations	12.16	13.42	17.13	10.27	9.00
Diluted EPS — Continuing Operations	12.14	13.40	17.08	10.24	8.96
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	363.4	405.2	496.3	609.5	694.4
Gross Margin %	69.01	70.85	72.20	73.52	74.65
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	87.4	95.6	146.9	217.7	250.5
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-6.2	-51.1
Net Income Adj (tax-effected)	64.4	69.5	90.8	167.6	179.4
EPS Adj	12.16	13.42	17.13	10.57	11.27
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Filed Debt Equity	—	—	0.27	0.09	0.00
Paid Up Equity Capital	52.9	53.0	53.0	159.2	159.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.